α-Cyperone (CYP) down-regulates NF-κB and MAPKs signaling, attenuating inflammation and extracellular matrix degradation in chondrocytes, to ameliorate osteoarthritis in mice

Aging (Albany NY). 2021 Jul 8;13(13):17690-17706. doi: 10.18632/aging.203259. Epub 2021 Jul 8.

Abstract

Inflammation and extracellular matrix (ECM) degradation have been implicated in the pathological process of osteoarthritis (OA). α-Cyperone is the main active component of the traditional Chinese medicine Cyperus rotundus L. In this study, we found that α-Cyperone abolished the IL-1β-induced production of inflammatory cytokines in isolated rat chondrocytes, such as cyclooxygenase-2 (COX-2), tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6) and inducible nitric oxide synthase (iNOS), in a dose-dependent manner (0.75, 1.5 or 3 μM). Also, the results showed that α-Cyperone downregulated the expression of metalloproteinases (MMPs) and thrombospondin motifs 5 (ADAMTS5), and upregulated the expression of type-2 collagen. Mechanistically, molecular docking tests revealed that α-Cyperone stably and effectively binds to p65, p38, extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK). α-Cyperone inhibited NF-κB activation by blocking its nuclear transfer, and decreasing the phosphorylation of mitogen-activated protein kinase (MAPKs). In addition, in vivo studies based on a mouse model of arthritis showed that α-Cyperone prevented the development of osteoarthritis. Therefore, α-Cyperone may be a potential anti-OA drug.

Keywords: extracellular matrix degradation; inflammation; osteoarthritis; α-Cyperone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Anti-Inflammatory Agents / therapeutic use*
  • Chondrocytes / drug effects
  • Cyperus
  • Down-Regulation
  • Extracellular Matrix / drug effects*
  • Extracellular Matrix / pathology
  • Extracellular Signal-Regulated MAP Kinases
  • Gene Expression Regulation / drug effects
  • Inflammation / drug therapy*
  • Interleukin-1beta / biosynthesis
  • Interleukin-1beta / genetics
  • MAP Kinase Signaling System / drug effects*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Molecular Docking Simulation
  • NF-kappa B / drug effects*
  • Naphthalenes / pharmacology*
  • Naphthalenes / therapeutic use*
  • Osteoarthritis / drug therapy*
  • Osteoarthritis / pathology
  • Osteoarthritis / prevention & control
  • Rats
  • Signal Transduction / drug effects*

Substances

  • Anti-Inflammatory Agents
  • IL1B protein, rat
  • Interleukin-1beta
  • NF-kappa B
  • Naphthalenes
  • Extracellular Signal-Regulated MAP Kinases
  • alpha-cyperone